0
Allergy and Airway: Asthma I |

Study of Hospitalized Cases With Anaphylactic Symptoms in Our Hospital in Japan FREE TO VIEW

Masaya Kainuma; Hiroyuki Nakaba; Kayoko Kawashima
Author and Funding Information

KKR Otemae Hospital, Osaka, Japan


Copyright 2016, American College of Chest Physicians. All Rights Reserved.


Chest. 2016;149(4_S):A10. doi:10.1016/j.chest.2016.02.012
Text Size: A A A
Published online

SESSION TITLE: Asthma I

SESSION TYPE: Original Investigation Poster

PRESENTED ON: Saturday, April 16, 2016 at 11:45 AM - 12:45 PM

PURPOSE: Annual number of deaths due to anaphylaxis is said to be almost 50 peoples in Japan, and death avoidance by anaphylactic shock is dependent on rapid epinephrine administration at onset. We review the hospitalized patients with anaphylactic symptoms and report the current state of the epinephrine self-injection prescription in our department.

METHODS: We targeted this time for the six cases of patients admitted with anaphylactic symptoms into our department from July 2014 to June 2015.

RESULTS: Their age was 33 ± 18 years, and male was three cases, female was three cases. We admitted an allergy history in all cases, and its contents were three cases of foods, one case of pharmaceuticals, one case of foods + exercises, and one case of other causes. During the visit, we observed skin symptoms in five cases (83%), mucous membrane symptoms in four cases (67%), gastrointestinal symptoms in one case (17%), respiratory symptoms in four cases (67%), and a temporary drop of blood pressure and loss of consciousness in one case (17%) (There were cases with multiple symptoms). Main cause of anaphylaxis was bee venom in one case (17%), pharmaceuticals in one case (17%), foods in two cases (33%), and unknown in two cases (33%). Three cases showed a natural improvement in the follow-up, and three cases showed improvement of symptoms with steroids intravenous administration. The general condition of all patients got better and they were discharged on the following day after admission to our hospital. We could not allow possession or use cases of the epinephrine self-injection prescription, and we carried out to guide three cases (50%) how to self-infect epinephrine on discharging hospital.

CONCLUSIONS: We reported six cases of patients admitted with anaphylactic symptoms and the current state of the epinephrine self-injection prescription in our department in Japan.

CLINICAL IMPLICATIONS: The epinephrine self-injection prescription is important for a patient that may cause anaphylaxis, and further enlightenment to doctors is expected from the viewpoint that only doctors of training sessions in advance can prescribe the epinephrine self-injection prescription.

DISCLOSURE: The following authors have nothing to disclose: Masaya Kainuma, Hiroyuki Nakaba, Kayoko Kawashima

No Product/Research Disclosure Information


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
Cashew Nut Allergy: Clinical Relevance and Allergen Characterisation. Clin Rev Allergy Immunol Published online Sep 1, 2016;
Long QT syndrome and life-threatening anaphylaxis: Is epinephrine safe? Ann Allergy Asthma Immunol Published online Aug 30, 2016;
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543